Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07506512 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss

Study acronym: TIME
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jul 2026 to Jul 2027 Eligibility criteria expanded, about 8 words · Secondary endpoints: details revised at 2 of 3 entries Show 2 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 2 of 3 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective cohort study to explore the optimal time interval between mifepristone and misoprostol administration for medical management of early pregnancy loss. Participants will be followed to assess treatment success, satisfaction, and side effects.
Trial Details
NCT Number NCT07506512
Lead Sponsor University of Pennsylvania
Conditions Early Pregnancy Loss
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov